Powles, T., Shamash, J., Berney, D., & Oliver, R. T. D. (2003). Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: A phase II study of the German Testicular Cancer Study Group. Nature Publishing Group.
Chicago ZitierstilPowles, T., J. Shamash, D. Berney, und R T D. Oliver. Irinotecan in Patients With Relapsed or Cisplatin-refractory Germ Cell Cancer: A Phase II Study of the German Testicular Cancer Study Group. Nature Publishing Group, 2003.
MLA ZitierstilPowles, T., J. Shamash, D. Berney, und R T D. Oliver. Irinotecan in Patients With Relapsed or Cisplatin-refractory Germ Cell Cancer: A Phase II Study of the German Testicular Cancer Study Group. Nature Publishing Group, 2003.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.